Quantum BioPharma Ltd.
QNTM
$3.89
-$0.16-3.95%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 28.98% | -67.15% | -83.61% | -54.08% | 69.31% |
| Total Receivables | -93.89% | -93.93% | -58.57% | -50.75% | -50.03% |
| Inventory | -45.15% | -55.55% | -- | -- | -- |
| Prepaid Expenses | -35.42% | -64.17% | -62.03% | 226.23% | -31.59% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 97.49% | 329.86% | 11,026.50% | -- | 2,652.29% |
| Total Current Assets | 4.40% | -46.25% | -32.51% | 3.21% | 8.06% |
|
|
|||||
| Total Current Assets | 4.40% | -46.25% | -32.51% | 3.21% | 8.06% |
| Net Property, Plant & Equipment | 34.95% | 29.83% | 38.97% | 212.18% | 4.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -8.71% | -8.53% | -8.35% | -8.17% | -8.01% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 0.35% | -34.80% | -25.61% | 0.33% | -3.66% |
|
|
|||||
| Total Accounts Payable | 49.74% | -39.11% | 93.35% | -48.07% | -49.67% |
| Total Accrued Expenses | 55.73% | 98.72% | -24.53% | 61.82% | 55.27% |
| Short-term Debt | -72.38% | 110.10% | 557.34% | 215.87% | 81.35% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 196.15% | 179.60% | 702.48% | 3,239.58% | 704.60% |
| Total Finance Division Other Current Liabilities | 77.19% | -- | 1,700.00% | -- | 83,741.25% |
| Total Other Current Liabilities | 77.19% | -- | 1,700.00% | -- | 83,741.25% |
| Total Current Liabilities | 58.02% | -9.29% | 80.56% | 162.64% | 163.62% |
|
|
|||||
| Total Current Liabilities | 58.02% | -9.29% | 80.56% | 162.64% | 163.62% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -72.38% | 110.10% | 557.34% | 215.87% | 81.35% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 58.02% | -9.29% | 80.56% | 162.64% | 163.62% |
|
|
|||||
| Common Stock & APIC | 14.72% | 12.98% | 12.43% | 12.36% | 9.33% |
| Retained Earnings | -17.24% | -15.21% | -17.10% | -16.58% | -13.06% |
| Treasury Stock & Other | -84.96% | -95.05% | -53.90% | -54.00% | -45.80% |
| Total Common Equity | -89.62% | -39.68% | -46.89% | -65.65% | -52.35% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -89.62% | -39.68% | -46.89% | -65.65% | -52.35% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -67.44% | -75.13% | -21.29% | -127.05% | -133.42% |
| Total Equity | -131.35% | -51.13% | -51.08% | -79.94% | -60.67% |
|
|
|||||